ARCHIVES

FDA To Issue “Complete Response” Letters To Drug Sponsors.

This article is from The Cancer Letter archive.

Vol. 34 No. 27 | July 11, 2008

Download PDF Visit The Full Archive

Related Articles

DCE Advisors Okay Study Of Cancer Risk in Breast Augmentation

November 22, 1991

Professional Societies: AACR Presents Awards At Annual Meeting

April 18, 1997

Addition of Cobimetinib Boosts PFS in BRAF Mutation-Positive Patients in Phase III Trial

July 25, 2014

DCCP Board Gives Concept Approval to Noncompeting Contracts

June 17, 1983

Lenalidomide Found Effective For Lymphoma In Phase II Trial

December 26, 2008

Cancer Organizations Continue Reform Lobbying: Target Issue Are Off-Label Drugs, Clinical Trials

March 26, 1993